# K120368: Capstone Control Spinal System

- Pathway: 510(k) (Traditional)
- Applicant: Medtronic Sofamor Danek USA, Inc.
- Decided: Apr 9, 2012 after 63 days
- Product code: MAX (Intervertebral Fusion Device With Bone Graft, Lumbar)
- Device class: 2
- Regulation: 21 CFR 888.3080
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 11 generations back to K841189 (1984). 57 ancestors in all.
761 later devices descend from it; 19 cite it directly.
1 of 819 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K073291: Capstone Spinal System, Medtronic Sofamor Danek USA, Inc. (2008) Summary page 3.
- K103731: Capstone R Spinal System, Medtronic Sofamor Danek (2011) Summary page 3.
- K111512: Bonebac T-Plif Intervertebral Body Fusion Device System, Thompson Mis, Inc. (2011)
- K033926: Hourglass Vertebral Body Spacer, Medtronic Sofamor Danek (2004) Summary page 3.
- K071795: Nuvasive Coroent System, Nuvasive, Inc. (2007) Summary page 3.
- K090353: Perimeter Interbody Fusion Device, Medtronic Sofamor Danek (2009) Summary page 3.
- K094025: Crescent Spinal System, Medtronic Sofamor Danek (2010) Summary page 3.

## Most influential descendants
- K121760: Capstone Spinal System (2012), 723 descendants of its own
- K123027: Capstone (R) Spinal System (2013), 709 descendants of its own
- K141896: Coroent System (2014), 480 descendants of its own
- K151472: NuVasive CoRoent Lumbar System (2015), 479 descendants of its own
- K143616: AccuLIF TL and PL Cage (2015), 469 descendants of its own

## Indications for use
The CAPSTONE CONTROLTM Spinal System is indicated for interbody fusion with autogenous bone graft in patients with Degenerative Disc Disease (DDD) at one or two levels from L2 to S1. These DDD patients may also have up to Grade I Spondylolisthesis or retrolisthesis at the involved levels. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six months of non-operative treatment. These implants may be implanted via an open or a minimally invasive posterior approach. Alternatively, these implants may also be implanted via an anterior and/or transforaminal approach. These implants are to be used with autogenous bone graft. These devices are intended to be used with supplemental fixation instrumentation, which has been cleared by the FDA for use in the lumbar spine.

Source page: https://510kreport.com/device/K120368
Methodology: https://510kreport.com/methodology